Cited by 100Hypothalamic control of reproductive hormonesNeuropeptides and Animal PhysiologyRegulation of Appetite and Obesity

Kisspeptin administration to women: a window into endogenous kisspeptin secretion and GnRH responsiveness across the menstrual cycle

Open access
Chan, Yee-Ming, Butler, James P., Sidhoum, Valerie F., Pinnell, Nancy E., Seminara, Stephanie B.·2012·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Kisspeptin is the most powerful known stimulus of GnRH-induced LH secretion across mammalian species. However, the effects of kisspeptin are just being explored, and the dynamics of kisspeptin responsiveness across the menstrual cycle are incompletely understood. OBJECTIVE: The objective of the study was to characterize the effects of kisspeptin on GnRH secretion in healthy women in different phases of the menstrual cycle. PARTICIPANTS AND INTERVENTION: Ten women in the early follicular phase, three women in the late follicular (preovulatory) phase, and 14 women in the midluteal phase received a bolus of kisspeptin 112-121 0.24 nmol/kg iv. An additional four women in the early to midfollicular phase received kisspeptin 112-121 0.72 nmol/kg iv. RESULTS: The response to kisspeptin varied depending on the phase of the menstrual cycle. LH pulses were observed immediately after kisspeptin administration in all luteal and preovulatory women. However, only half the women in the early follicular phase had unambiguous kisspeptin responses. Increasing the kisspeptin dose did not increase the LH response in early to midfollicular phase women. Kisspeptin did not appear to reset the GnRH pulse generator in women as it does in men. CONCLUSIONS: Differences in responses to exogenous kisspeptin across the menstrual cycle suggest that kisspeptin tone is higher in the early follicular phase compared with other cycle phases. The mechanisms that determine the timing of GnRH pulse generation in men and women appear to be distinct.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2012-1282

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Repetitive bolus administration of kisspeptin at a physiologic dose and at a frequency of 1 bolus/hour increased mean LH levels and LH pulse frequency in the entire cohort (n = 11) of hyperprolactinemic women.

    “Repetitive bolus administration of kisspeptin at a physiologic dose (30, 32) and at a frequency of 1 bolus/hour increased mean LH levels and LH pulse frequency in the entire cohort (n = 11) of hyperprolactinemic women.”

    From Kisspeptin Overcomes GnRH Neuronal Suppression Secondary to Hyperprolactinemia in Humans (2022) · cites this paper as [32]

    The Methods report a single kisspeptin bolus in healthy women, and the early-follicular Results report increased mean LH afterward. The cited paper does not establish the claimed effect of hourly boluses on LH pulse frequency in 11 hyperprolactinemic women, nor does the identified passage describe the dose as physiologic. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The mean LH amplitude in response to the first kisspeptin IVB in hyperprolactinemic women was comparable to that observed in normoprolactinemic female volunteers in the midluteal phase.

    “Moreover, the mean LH amplitude in response to the first kisspeptin IVB in hyperprolactinemic women was comparable to that observed in normoprolactinemic female volunteers in the midluteal phase (32).”
  • This mean estradiol value is comparable to the estradiol levels observed in healthy volunteers in the early follicular phase of the menstrual cycle undergoing a similar protocol (35 ± 3 pg/mL).

    “This value is comparable to the estradiol levels observed in healthy volunteers in the early follicular phase of the menstrual cycle undergoing a similar protocol (35 ± 3 pg/mL) (32).”
  • Administration of kisspeptin results in increases in plasma LH concentrations in healthy men, and in women kisspeptin also induces LH release, although the response varies across the menstrual cycle.

    “Administration of kisspeptin results in increases in plasma LH concentrations in healthy men,54,55 and in women kisspeptin also induces LH release, although the response varies across the menstrual cycle.56”

    From Pubertal development and regulation (2016) · cites this paper as [56]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chan, Y.-M., Butler, J. P., Sidhoum, V. F., Pinnell, N. E., & Seminara, S. B.
Affiliations
  • Harvard University (US)
  • Brigham and Women's Hospital (US)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2012-08
Volume
97
Issue
8
Pages
E1458-E1467
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2076309282
Cited by
100
References
47
Citations by year
2026: 4 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 10 · 2015: 13 · 2014: 13 · 2013: 8 · 2012: 3
FWCI
13.78
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Massachusetts General Hospital
  • Harvard University
  • Harvard Catalyst
  • National Institutes of Health
  • National Center for Research Resources (UL1RR025758)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD43341, R01HD043341, K24HD067388)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
kisspeptin, GnRH secretion, luteinizing hormone, menstrual cycle, follicular phase, luteal phase, GnRH pulse generator, LH pulsatility
MeSH terms
Adult, Female, Humans, Luteinizing Hormone, Gonadotropin-Releasing Hormone, Menstrual Cycle, Young Adult, Kisspeptins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review